Poisons Standard Amendment (Hydroxychloroquine and Salbutamol) Instrument 2020

Dated 23 March 2020

Tony Gill

Principal Medical Adviser

Prescription Medicines Authorisation Branch

Health Products Regulation Group

Contents

1  Name........................................................................................................................................ 1

2  Commencement........................................................................................................................ 1

3  Authority.................................................................................................................................. 1

4  Schedules................................................................................................................................. 1

Schedule 1—Amendments                                                                                           2

Part 1—Hydroxychloroquine                                                                                  2

Poisons Standard February 2020                                                                                                      2

Part 2—Salbutamol                                                                                                  3

Poisons Standard February 2020                                                                                                      3

1  Name

                   This instrument is the Poisons Standard Amendment (Hydroxychloroquine and Salbutamol) Instrument 2020.

2  Commencement

             (1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

             (2)  Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

                   This instrument is made under paragraph 52D(2)(a) of the Therapeutic Goods Act 1989.

4  Schedules

                   Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1—Amendments

Part 1—Hydroxychloroquine

Poisons Standard February 2020

1  Schedule 4 of Part 4 of Schedule 2 (entry for hydroxychloroquine)

Repeal the entry, substitute:

# HYDROXYCHLOROQUINE.

2  At the end of Appendix D of Part 5 of Schedule 2

            Add:

3  Schedule 2 (index)

Omit the entry for hydroxychloroquine, substitute:

HYDROXYCHLOROQUINE

Schedule 4
Appendix D, Item 8

Part 2—Salbutamol

Poisons Standard February 2020

4  Schedule 3 of Part 4 of Schedule 2 (entry for salbutamol)

Repeal the entry, substitute:

SALBUTAMOL as the only therapeutically active substance:

a)   in metered aerosols delivering 100 micrograms or less of salbutamol per metered dose; or

b)   in dry powders for inhalation delivering 200 micrograms or less of salbutamol per dose; and

where supply is limited:

c)   to persons with evidence of a medically diagnosed lung condition; or

d)   to persons with a record of previous supply from the pharmacist; or

e)   to persons authorised under a law of a State or Territory to use or supply salbutamol in the practice of their profession; or

f)   for use in institutional first aid; and

where paragraph (c) or (d) applies—supply is limited to one primary pack of salbutamol per person.